Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03345147
Other study ID # CIE-REV 061/2016
Secondary ID
Status Completed
Phase N/A
First received August 25, 2017
Last updated November 13, 2017
Start date January 13, 2017
Est. completion date October 30, 2017

Study information

Verified date November 2017
Source Institute of Nutrition of Central America and Panama
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to assess whether 3-5 years-old children who have Vitamin A intakes above the tolerable upper intake level (UL=900 ug per day) have higher total body Vitamin A stores and biomarkers of excessive vitamin A status, compared to children with Normal Vitamin A intakes (250-600 ug per day).


Description:

The goal of this study is to assess whether VA intakes above the tolerable upper intake level (UL) and exposure to multiple programs are associated with are associated with 1) exposure to multiple VA intervention programs, and 2) elevated liver vitamin A concentration and biomarkers of excess vitamin A. Guatemala was selected as a study site because the country has a long standing national fortification program for vitamin A in sugar (law since 1975, re-launched and maintained since the 90´s). Typically, fortified sugar is used in more than 90% of households at average concentrations of 9 to 10 µg/g of sugar. VA fortified foods, in the form of fortified sugar, foods prepared with fortified sugar and other fortified foods, reach children from 2 years old to adulthood. On the other hand, high dose VA supplements, provided by local health services, only reached 10.5% of children ages 6-59 month in 2013. Children ages 2-3 and 4-5 years old with VA intakes above and below the UL will be recruited together with their mothers to assess the cumulative effect of fortification on young children and their mothers. Data from Program of Food and Nutrition Security (PROSAN), of the Ministry of Health, Guatemala in 2013, shows that coverage in the 30 Health Areas of the country is 17.9%, the lowest is 4.4% (San Marcos) and the largest 33% (Petén). Four of the 30 Region Areas correspond to the Department of Guatemala, in which urban and peri-urban areas of Guatemala City are included. In Central and North-West Guatemala Areas, coverage is 23 and 22% respectively, both above national average coverage and within the 10 out of 30 top coverages. According to PROSAN data for Micronutrient Powders in 2013, all four regions North-East, North-West, South, and Central Guatemala areas are also around or above the national coverage (14%) with 21.8, 11.2, 17.3 and 13.8% coverage. Another advantage of remaining in the 4 areas of Health around Guatemala city is that the four combined amount for 300,000 children of 0-59 month-old, that is more than 15% of the national children population reported. Even if coverages are low, population density will easier children recruitment.


Recruitment information / eligibility

Status Completed
Enrollment 178
Est. completion date October 30, 2017
Est. primary completion date September 13, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 5 Years
Eligibility Inclusion Criteria:

- Children 3-5 years old and their mothers

- Child VA intake must be above 250 micrograms/day

- Children must be apparently healthy, Hemoglobin>9 g/dL at recruitment point, C-reactive protein<5 mg/L. For Women, Hemoglobin>10 g/dL, C-reactive protein<5 mg/L

Exclusion Criteria:

°Children with Congenital or chronical diseases, reported illnesses 1 week before the test. For Women: Pregnancy or lactation, Previously known Chronic Diseases

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High Vitamin A intake
Total Vitamin A stores will be assessed by isotopic measurement, 13C-Retinol will be given to the subject and blood wil be drawn on Day 4 to assess the isotopic dilution in the plasma. Other biochemical indicators will be assessed too, along with Dietary assessment (Food Frequency, 24 hours recalls).
Normal Vitamin A intake
Total Vitamin A stores will be assessed by isotopic measurement, 13C-Retinol will be given to the subject and blood wil be drawn on Day 4 to assess the isotopic dilution in the plasma. Other biochemical indicators will be assessed too, along with Dietary assessment (Food Frequency, 24 hours recalls).

Locations

Country Name City State
Guatemala Sacatepequez City Hall Guatemala
Guatemala Mixco, La Comunidad City Hall Guatemala City
Guatemala Santa Catarina Pinula City Hall Guatemala City

Sponsors (4)

Lead Sponsor Collaborator
Institute of Nutrition of Central America and Panama Bill and Melinda Gates Foundation, International Atomic Energy Agency, Newcastle University

Country where clinical trial is conducted

Guatemala, 

Outcome

Type Measure Description Time frame Safety issue
Other Hemoglobin concentration in children Measured with Quik Read Pro portable Device At recruitment
Other Children weight and length Measured with Scale and Measurement Rod At recruitment
Other Systemic inflammation in children Measured with Quik Read Pro portable Device At recruitment
Other Iron status in children Estimated by different techniques 28-day study period
Other Zinc status in children Estimated by atomic emission spectrometry 28-day study period
Primary Total Vitamin A stores among 3-5 years-old children, in micromoles Estimated using Carbon 13 (13C) 13C-retinol dilution method, by the ratio of Labelled (stable isotope) versus no labelled Vitamin A in plasma 4 days after dose of labelled VA is given. 28-day study period
Primary Total dietary vitamin A intake among 3-5 years-old children, in micrograms (ug) Estimated using 24-hour dietary recalls, observed weigh food records, food and supplement frequency questionnaire 28-day study period
Secondary Plasma retinol among 3-5 years-old children Estimated by High Performance Liquid Chromatography (HPLC) 28-day study period
Secondary Plasma retinol binding protein among 3-5 years-old children Estimated by ELISA 28-day study period
Secondary Plasma Transthyretin among 3-5 years-old children Estimated by immunometric automated assay 28-day study period
Secondary Bone Health markers among 3-5 years-old children Estimated by different techniques 28-day study period
Secondary Liver function markers among 3-5 years-old children Estimated by different techniques 28-day study period
Secondary Plasma retinol among women Estimated by HPLC 28-day study period
Secondary Plasma retinol binding protein among women Estimated by ELISA 28-day study period
Secondary Plasma Transthyretin among women Estimated by immunometric automated assay 28-day study period
Secondary Total dietary vitamin A intake among women, in micrograms (ug) Estimated using 24-hour dietary recalls, observed weigh food records, food and supplement frequency questionnaire 28-day study period
See also
  Status Clinical Trial Phase
Recruiting NCT03056625 - Efficacy of Vitamin A Fortified Rice in Lactating Thai Women N/A
Completed NCT01803659 - Effect of Small Daily Doses of B-carotene on Breast Milk Retinol N/A
Completed NCT00636038 - Bioavailability of Yellow Maize Carotenoids in Humans Phase 1
Completed NCT01920646 - Effect of African Leafy Vegetables on Nutritional Status of South African School Children. N/A
Completed NCT03030339 - Vitamin A Status and Risk of Excessive Vitamin A Intake Among Urban Filipino Children N/A